L Herrera
Overview
Explore the profile of L Herrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
228
Citations
1621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blohm L, De Sousa J, Roschman-Gonzalez A, Ferrer E, Morocoima A, Herrera L
J Parasit Dis
. 2022 Mar;
46(1):37-46.
PMID: 35299905
The domiciliation of and and the entomological risk indicators for the transmission of , an etiological agent of Chagas Disease-CD, were studied in rural villages of Anzoátegui state, Venezuela. Nightly...
2.
Barozet E, Valenzuela C, Cifuentes L, Verdugo R, Herrera L, Acuna M, et al.
Biodemography Soc Biol
. 2021 Jun;
66(2):156-171.
PMID: 34182852
Studies of the current Chilean population performed using classical genetic markers have established that the Chilean population originated primarily from the admixture of European people, particularly Spaniards, and Amerindians. A...
3.
Eguizabal C, Herrera L, Ingles-Ferrandiz M, Izpisua Belmonte J
Stem Cell Res Ther
. 2021 Apr;
12(1):250.
PMID: 33906672
No abstract available.
4.
Ingles-Ferrandiz M, Martin-Inaraja M, Herrera L, Villaverde M, Santos S, Vesga M, et al.
Stem Cell Res
. 2020 Nov;
49:102082.
PMID: 33221676
APDS2 is caused by mutations in PIK3R1 gene resulting in constitutive PI3Kδ activation. PI3Kδ is predominantly expressed in leukocytes and plays critical roles in regulating immune responses. Here we first...
5.
Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
Eguizabal C, Herrera L, Ingles-Ferrandiz M, Izpisua Belmonte J
Stem Cell Res Ther
. 2020 Oct;
11(1):453.
PMID: 33109263
Primary immunodeficiency diseases (PIDs) are rare diseases that are characterized by genetic mutations that damage immunological function, defense, or both. Some of these rare diseases are caused by aberrations in...
6.
Viettri M, Herrera L, Aguilar C, Morocoima A, Reyes J, Lares M, et al.
J Vector Borne Dis
. 2020 Jul;
56(3):252-262.
PMID: 32655075
Background & Objectives: Trypanosoma cruzi and Leishmania spp. are protozoans that cause American trypanosomiasis and leishmaniasis, respectively. In endemic foci where both diseases coincide, coinfection can occur. The objective of...
7.
Loza A, Del Nogal F, Macias D, Leon C, Socias L, Herrera L, et al.
Med Intensiva (Engl Ed)
. 2020 Apr;
44(8):463-474.
PMID: 32229047
Objective: To identify predictors of mortality and neurological function in adult ICU patients recovering from cardiac arrest. Design: A prospective cohort multicenter study was carried out. Setting: Forty-six polyvalent ICUs....
8.
Herrera L, Santos S, Vesga M, Anguita J, Martin-Ruiz I, Carrascosa T, et al.
Sci Rep
. 2019 Dec;
9(1):18729.
PMID: 31822751
Among hematological cancers, Acute Lymphoblastic Leukemia (ALL) and Chronic Lymphocytic Leukemia (CLL) are the most common leukemia in children and elderly people respectively. Some patients do not respond to chemotherapy...
9.
Eguizabal C, Herrera L, De Onate L, Montserrat N, Hajkova P, Izpisua Belmonte J
Stem Cells
. 2016 Jun;
34(9):2418-28.
PMID: 27300161
Epigenetic reprogramming is a central process during mammalian germline development. Genome-wide DNA demethylation in primordial germ cells (PGCs) is a prerequisite for the erasure of epigenetic memory, preventing the transmission...
10.
Sung H, Castro I, Gonzalez S, Aguilera S, Smorodinsky N, Quest A, et al.
Oral Dis
. 2015 Mar;
21(6):730-8.
PMID: 25757505
Objectives: To evaluate the expression and localization of MUC1/SEC and MUC1/Y isoforms in labial salivary glands (LSG) from Sjögren's syndrome patients (SS patients), as well as their in vitro expression...